Peptides Codex
Home
Signaling peptide (kinin)

Bradykinin

Bradykinin is a nine-amino-acid signaling peptide of the kinin group, released from kininogen by kallikrein. Acting through B2 and B1 receptors, it drives vasodilation, increased vascular permeability, pain signaling and inflammation, and is central to the kallikrein-kinin system. This page is educational and not medical advice.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
9 aa
Class
Signaling peptide (kinin)
Function
Vasodilator and inflammatory mediator via bradykinin B2/B1 receptors
Context
Vascular, inflammation and pain physiology research

A nine-residue kinin that dilates vessels, raises permeability and signals pain during inflammation.

Also known as: BK · kallidin-related kinin

Part of the Foundational & therapeutic peptides cluster

Overview

Bradykinin is a nine-amino-acid signaling peptide of the kinin group, released from kininogen by kallikrein. Acting through B2 and B1 receptors, it drives vasodilation, increased vascular permeability, pain signaling and inflammation, and is central to the kallikrein-kinin system. This page is educational and not medical advice.

Source & context

Biological / chemical source: Cleaved from kininogen by kallikrein enzymes

Primary research or clinical context: Vascular, inflammation and pain physiology research

Generation and receptors

Bradykinin (RPPGFSPFR) is cleaved from high-molecular-weight kininogen by plasma kallikrein. It acts mainly at the constitutive B2 receptor and, during injury, at the inducible B1 receptor, and is rapidly degraded by kininases including angiotensin-converting enzyme (ACE).

Why it matters

Because ACE also inactivates bradykinin, its accumulation explains the cough and angioedema seen with ACE-inhibitor drugs. The peptide is a key research model for vascular permeability, nociception and hereditary angioedema, where kallikrein-kinin signaling is dysregulated.

Sequence

One-letter sequence commonly cited for Bradykinin (educational; isoforms and modifications may differ):

RPPGFSPFR

RPPGFSPFR

R1P2P3G4F5S6P7F8R9
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

FAQ about Bradykinin

What is Bradykinin?+

Bradykinin is a nine-amino-acid signaling peptide of the kinin group, released from kininogen by kallikrein. Acting through B2 and B1 receptors, it drives vasodilation, increased vascular permeability, pain signaling and inflammation, and is central to the kallikrein-kinin system. This page is educational and not medical advice.

Is Bradykinin an approved medicine?+

Bradykinin is discussed here as a research / educational topic. Vascular, inflammation and pain physiology research. This is not medical advice.

What is the typical length of Bradykinin?+

Bradykinin is commonly described as approximately 9 amino acids (Signaling peptide (kinin)).

Related peptides

References & further reading

  1. 1.Wikipedia — Bradykinin
  2. 2.PubChem — Bradykinin (CID 439201)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Bradykinin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.